Snowden Capital Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,288
| Closed | -$354K | – | 1197 |
|
|
2024
Q3 | $354K | Buy |
12,288
+199
| +2% | +$5.74K | 0.01% | 920 |
|
|
2024
Q2 | $464K | Buy |
12,089
+3,191
| +36% | +$122K | 0.01% | 784 |
|
|
2024
Q1 | $523K | Sell |
8,898
-264
| -3% | -$15.5K | 0.02% | 743 |
|
|
2023
Q4 | $548K | Sell |
9,162
-288
| -3% | -$17.2K | 0.02% | 660 |
|
|
2023
Q3 | $359K | Buy |
9,450
+3,417
| +57% | +$130K | 0.02% | 791 |
|
|
2023
Q2 | $550K | Buy |
6,033
+179
| +3% | +$16.3K | 0.02% | 691 |
|
|
2023
Q1 | $386K | Buy |
+5,854
| New | +$386K | 0.02% | 842 |
|
|
2019
Q3 | – | Sell |
-10,914
| Closed | -$277K | – | 511 |
|
|
2019
Q2 | $277K | Buy |
+10,914
| New | +$277K | 0.03% | 421 |
|